Myer (ASX:MYR) share price jumps 7% on strong FY 2021 results

Myer was very profitable again in FY 2021…

| More on:
a family with shopping bags walks inside a shopping mall with shops in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Myer Holdings Ltd (ASX: MYR) share price is charging higher following the release of its full year results.

In morning trade, the department store operator's shares are up 7% to 54.5 cents.

Myer share price higher on profit rebound

  • Total sales increased 5.5% to $2,658.3 million
  • Online sales up 27.7% to $539.5 million
  • Gross profit margin lifted 168 basis points to 39.7%
  • Net profit after tax of $51.7 million, compared to a loss of $13.4 million in FY 2020
  • Dividend remains suspended due to lockdown uncertainty

What happened in FY 2021 for Myer?

For the 53 weeks ended 31 July 2021, Myer reported a 5.5% increase in sales to $2,658.3 million. A key driver of this growth was its online business, which delivered a 27.7% lift in sales to $539.5 million. This means that 20.3% of Myer's sales are now generated online.

Complementing its solid sales growth was margin expansion, which was underpinned by the success of its Customer First Plan and its focus on profit sales. This led to Myer delivering a net profit after tax of $51.7 million for FY 2021. This is a huge improvement on the $13.4 million loss it recorded a year earlier.

Despite its strong profit rebound, lockdown uncertainty means that its dividend will remain suspended for the time being.

What did management say?

Myer's Chief Executive Officer and Managing Director, John King, was very pleased with the company's performance in FY 2021.

He commented: "This result is a testament to the hard work of our team, and we are starting to see the business thrive despite the extraordinary market conditions. Our significantly improved FY21 results, including growth in profitability for both the first and second half, demonstrates the Customer First Plan is getting real traction."

"Despite the on again off again nature of physical retail over FY21, when combined with continued growth in the online business, we delivered solid sales growth when not impacted by lockdowns, particularly in 2H21," he added.

Mr King also highlighted that the company's focus on profitable sales has been key to the retailer's resurgence.

He explained: "As we have consistently said over the past three years our focus has been on profitable sales, growing the online business, disciplined management of costs, cash, and inventory, space optimisation and the deleveraging of our balance sheet. The successful execution of these, and many more strategic initiatives, has delivered solid growth across all our key metrics in FY21."

"We continue to improve our merchandise cycle as evidenced by improved margins and stockturn, reduced aged stock and record low levels of clearance inventory," added King.

Outlook

One thing that could be holding the Myer share price back a touch today is that there was no guidance provided by management. Though, it did provide a bit of colour on current trading.

The company advised: "Trade remains subdued with lockdowns however there is strong performance in Online and our non-lockdown stores which provides optimism once lockdowns ease."

Management also advised that it was pleased with how it was positioned going into the Christmas trading period.

Mr King commented: "The business is well placed ahead of the upcoming peak trading period and the team are focused on remaining agile in response to the various State-based lockdowns and travel restrictions."

The Myer share price is now up 82% in 2021.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »